Nanomedicine for neuroprotection
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Nanomedicine (London, England) - 14(2019), 2 vom: 01. Jan., Seite 127-130 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Friedrich, Ralf P [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 26.11.2019 Date Revised 26.11.2019 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.2217/nnm-2018-0401 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM291565921 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM291565921 | ||
003 | DE-627 | ||
005 | 20231225071140.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2217/nnm-2018-0401 |2 doi | |
028 | 5 | 2 | |a pubmed24n0971.xml |
035 | |a (DE-627)NLM291565921 | ||
035 | |a (NLM)30526308 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Friedrich, Ralf P |e verfasserin |4 aut | |
245 | 1 | 0 | |a Nanomedicine for neuroprotection |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.11.2019 | ||
500 | |a Date Revised 26.11.2019 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Introductory Journal Article | |
650 | 4 | |a ischemia-reperfusion injury | |
650 | 4 | |a nanoparticles for disease diagnosis | |
650 | 4 | |a neurodegenerative diseases | |
650 | 7 | |a Neuroprotective Agents |2 NLM | |
650 | 7 | |a Catechin |2 NLM | |
650 | 7 | |a 8R1V1STN48 |2 NLM | |
650 | 7 | |a epigallocatechin gallate |2 NLM | |
650 | 7 | |a BQM438CTEL |2 NLM | |
650 | 7 | |a Sphingomyelin Phosphodiesterase |2 NLM | |
650 | 7 | |a EC 3.1.4.12 |2 NLM | |
700 | 1 | |a Pöttler, Marina |e verfasserin |4 aut | |
700 | 1 | |a Cicha, Iwona |e verfasserin |4 aut | |
700 | 1 | |a Unterweger, Harald |e verfasserin |4 aut | |
700 | 1 | |a Janko, Christina |e verfasserin |4 aut | |
700 | 1 | |a Alexiou, Christoph |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nanomedicine (London, England) |d 2006 |g 14(2019), 2 vom: 01. Jan., Seite 127-130 |w (DE-627)NLM17228452X |x 1748-6963 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2019 |g number:2 |g day:01 |g month:01 |g pages:127-130 |
856 | 4 | 0 | |u http://dx.doi.org/10.2217/nnm-2018-0401 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2019 |e 2 |b 01 |c 01 |h 127-130 |